BioHarvest Sciences Inc.
BHST
$7.20
-$0.4621-6.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.08% | 61.02% | 101.88% | 119.16% | 147.06% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 47.08% | 61.02% | 101.88% | 119.16% | 147.06% |
| Cost of Revenue | 39.47% | 41.67% | 57.21% | 77.92% | 70.75% |
| Gross Profit | 53.01% | 79.81% | 157.56% | 180.47% | 279.17% |
| SG&A Expenses | 49.40% | 16.44% | 77.61% | 19.60% | 24.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 41.53% | 26.82% | 64.72% | 38.72% | 44.06% |
| Operating Income | -20.72% | 33.82% | -4.73% | 38.23% | 43.83% |
| Income Before Tax | 65.05% | 59.25% | -55.70% | 75.89% | -775.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 64.47% | 59.14% | -55.70% | 75.89% | -775.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 64.47% | 59.14% | -55.70% | 75.89% | -775.13% |
| EBIT | -20.72% | 33.82% | -4.73% | 38.23% | 43.83% |
| EBITDA | -8.02% | 35.78% | 2.18% | 46.77% | 47.71% |
| EPS Basic | 71.83% | 66.91% | -20.51% | 80.23% | -747.43% |
| Normalized Basic EPS | 72.26% | 66.99% | -20.52% | 80.18% | -747.59% |
| EPS Diluted | 71.83% | 66.91% | -20.51% | 80.23% | -747.43% |
| Normalized Diluted EPS | 72.26% | 66.99% | -20.52% | 80.18% | -747.59% |
| Average Basic Shares Outstanding | 26.06% | 23.45% | 29.22% | 21.84% | 3.30% |
| Average Diluted Shares Outstanding | 26.06% | 23.45% | 29.22% | 21.84% | 3.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |